Q32 Bio Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.5% | +223.7% | -18.5% | -15.8% | -11.7% | -14.4% | -16.4% | -12.6% | +6.9% | +3.1% | +82.0% | |
| – | -26.6% | +380.7% | -19.1% | -15.9% | -12.8% | -16.2% | -15.0% | -12.9% | +8.3% | +3.3% | +92.8% | |
| – | -29.3% | +350.9% | -15.5% | -8.8% | -12.5% | -16.0% | -16.3% | -10.6% | -1.5% | +5.1% | +109.4% | |
| – | -29.3% | +428.2% | -20.4% | -17.2% | -12.5% | -16.0% | -16.3% | -10.6% | -1.5% | +5.1% | +109.4% | |
| – | +11.0% | -25.4% | +0.0% | +0.0% | -1.4% | +0.0% | +0.0% | +0.2% | +770.0% | +11.5% | -55.6% | |
| – | +1.8% | +0.0% | -126.8% | – | – | – | – | – | – | – | – | |
| – | +9.4% | -55.0% | -12.4% | -4.9% | +0.5% | -4.1% | -5.7% | -2.7% | -74.1% | -12.1% | -42.6% | |
| – | -80.4% | +133.6% | -47.8% | -16.3% | +14.5% | -11.5% | -20.9% | -3.7% | +2.1% | -6.0% | -49.4% | |
| – | -96.3% | +228.2% | -70.9% | +89.5% | +44.9% | +42.7% | +30.0% | +0.3% | +0.4% | +0.4% | -89.4% | |
| – | +89.6% | +43.0% | -49.9% | -49.4% | +137.6% | -9.3% | -66.4% | +6.9% | -9.7% | -25.7% | +139.7% | |
| – | +87.6% | +0.0% | +33.6% | -11.8% | -13.7% | -15.9% | -18.9% | -23.3% | -30.6% | -44.2% | – | |
| – | – | – | -31.3% | -45.4% | -69.0% | -170.7% | – | – | – | +10.2% | +128.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | +0.3% | +0.9% | -10.0% | +12.2% | +0.0% | +0.4% | +7.9% | +6.7% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.